Position in GLUE
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$6,919,651
+$2,198,863 QoQ
Shares Held
285,936
-0.4% QoQ
Ownership
0.335%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#47
of 193 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GLUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TD Asset Management Inc holds $1,129,937,988 across 119 Biotechnology names. GLUE ranks #34 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
259,317 | $161,694,522 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
207,960 | $103,299,970 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
1,115,730 | $87,328,187 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,696 | $70,349,506 | |
| 5 | CYTK |
Cytokinetics Inc
|
385,130 | $32,809,224 | |
| 6 | RPRX |
Royalty Pharma plc
|
567,497 | $31,819,556 | |
| 7 | ASND |
Ascendis Pharma A/S
|
119,085 | $31,762,351 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
272,900 | $31,293,443 |
All Filings in GLUE
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,919,651 | 285,936 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $4,720,788 | 286,978 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $3,347,115 | 213,464 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,275,097 | 172,078 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $776,071 | 172,078 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $798,441 | 172,078 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $1,527,466 | 220,096 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,026,588 | 193,696 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $724,423 | 193,696 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $1,361,834 | 193,168 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,091,399 | 193,168 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $925,274 | 193,168 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $798,833 | 116,618 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,097,252 | 140,854 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,071,898 | 140,854 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,150,777 | 140,854 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,362,058 | 140,854 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $1,974,773 | 140,854 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $2,699,033 | 132,176 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $863,661 | 38,764 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $879,942 | 38,764 | Shares | Sole | 2021-08-11 | |
| No filing history on record for this holder in this stock. | ||||||